Affordable Access

Recombinant erythropoietin in clinical practice.

Authors
Type
Published Article
Journal
Postgraduate medical journal
Publication Date
Volume
79
Issue
933
Pages
367–376
Identifiers
PMID: 12897214
Source
Medline
License
Unknown

Abstract

The introduction of recombinant human erythropoietin (RHuEPO) has revolutionised the treatment of patients with anaemia of chronic renal disease. Clinical studies have demonstrated that RHuEPO is also useful in various non-uraemic conditions including haematological and oncological disorders, prematurity, HIV infection, and perioperative therapies. Besides highlighting both the historical and functional aspects of RHuEPO, this review discusses the applications of RHuEPO in clinical practice and the potential problems of RHuEPO treatment.

Statistics

Seen <100 times